{"pmid":32080993,"title":"The Author's Response: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR.","text":["The Author's Response: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR.","J Korean Med Sci","Lim, Jaegyun","Jeon, Seunghyun","Shin, Hyun Young","Kim, Moon Jung","Seong, Yu Min","Lee, Wang Jun","Choe, Kang Won","Kang, Yu Min","Lee, Baeckseung","Park, Sang Joon","32080993"],"journal":"J Korean Med Sci","authors":["Lim, Jaegyun","Jeon, Seunghyun","Shin, Hyun Young","Kim, Moon Jung","Seong, Yu Min","Lee, Wang Jun","Choe, Kang Won","Kang, Yu Min","Lee, Baeckseung","Park, Sang Joon"],"date":"2020-02-22T11:00:00Z","year":2020,"_id":"32080993","week":"20208|Feb 17 - Feb 23","doi":"10.3346/jkms.2020.35.e89","source":"PubMed","locations":["South Korea"],"countries":["Korea, Republic of"],"countries_codes":["KOR|Korea, Republic of"],"topics":["Treatment"],"weight":1,"_version_":1661359647392530432,"score":6.7365713,"similar":[{"pmid":32056407,"pmcid":"PMC7025910","title":"Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR.","text":["Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR.","Since mid-December of 2019, coronavirus disease 2019 (COVID-19) infection has been spreading from Wuhan, China. The confirmed COVID-19 patients in South Korea are those who came from or visited China. As secondary transmissions have occurred and the speed of transmission is accelerating, there are rising concerns about community infections. The 54-year old male is the third patient diagnosed with COVID-19 infection in Korea. He is a worker for a clothing business and had mild respiratory symptoms and intermittent fever in the beginning of hospitalization, and pneumonia symptoms on chest computerized tomography scan on day 6 of admission. This patient caused one case of secondary transmission and three cases of tertiary transmission. Hereby, we report the clinical findings of the index patient who was the first to cause tertiary transmission outside China. Interestingly, after lopinavir/ritonavir (Kaletra, AbbVie) was administered, beta-coronavirus viral loads significantly decreased and no or little coronavirus titers were observed.","J Korean Med Sci","Lim, Jaegyun","Jeon, Seunghyun","Shin, Hyun Young","Kim, Moon Jung","Seong, Yu Min","Lee, Wang Jun","Choe, Kang Won","Kang, Yu Min","Lee, Baeckseung","Park, Sang Joon","32056407"],"abstract":["Since mid-December of 2019, coronavirus disease 2019 (COVID-19) infection has been spreading from Wuhan, China. The confirmed COVID-19 patients in South Korea are those who came from or visited China. As secondary transmissions have occurred and the speed of transmission is accelerating, there are rising concerns about community infections. The 54-year old male is the third patient diagnosed with COVID-19 infection in Korea. He is a worker for a clothing business and had mild respiratory symptoms and intermittent fever in the beginning of hospitalization, and pneumonia symptoms on chest computerized tomography scan on day 6 of admission. This patient caused one case of secondary transmission and three cases of tertiary transmission. Hereby, we report the clinical findings of the index patient who was the first to cause tertiary transmission outside China. Interestingly, after lopinavir/ritonavir (Kaletra, AbbVie) was administered, beta-coronavirus viral loads significantly decreased and no or little coronavirus titers were observed."],"journal":"J Korean Med Sci","authors":["Lim, Jaegyun","Jeon, Seunghyun","Shin, Hyun Young","Kim, Moon Jung","Seong, Yu Min","Lee, Wang Jun","Choe, Kang Won","Kang, Yu Min","Lee, Baeckseung","Park, Sang Joon"],"date":"2020-02-15T11:00:00Z","year":2020,"_id":"32056407","week":"20207|Feb 10 - Feb 16","doi":"10.3346/jkms.2020.35.e79","keywords":["COVID-19","Coronavirus","Pneumonia","Real-Time Reverse-Transcriptase Polymerase Chain Reaction","Tertiary Infection","Viral Load"],"link_comment_in":"32080992","source":"PubMed","locations":["Wuhan","South Korea","China"],"countries":["Korea, Republic of","China"],"countries_codes":["KOR|Korea, Republic of","CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1661359647285575680,"score":159.5928},{"pmid":32080992,"pmcid":"PMC7036343","title":"Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR.","text":["Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR.","J Korean Med Sci","Kim, Jin Yong","32080992"],"journal":"J Korean Med Sci","authors":["Kim, Jin Yong"],"date":"2020-02-22T11:00:00Z","year":2020,"_id":"32080992","week":"20208|Feb 17 - Feb 23","doi":"10.3346/jkms.2020.35.e88","link_comment_for":"32056407","source":"PubMed","locations":["South Korea"],"countries":["Korea, Republic of"],"countries_codes":["KOR|Korea, Republic of"],"topics":["Treatment"],"weight":1,"_version_":1661359647392530433,"score":159.18959},{"pmid":32114746,"title":"[Drug interaction monitoring of lopinavir / ritonavir in COVID-19 patients with cancer].","text":["[Drug interaction monitoring of lopinavir / ritonavir in COVID-19 patients with cancer].","Zhonghua Nei Ke Za Zhi","Zheng, X W","Tao, G","Zhang, Y W","Yang, G N","Huang, P","32114746"],"journal":"Zhonghua Nei Ke Za Zhi","authors":["Zheng, X W","Tao, G","Zhang, Y W","Yang, G N","Huang, P"],"date":"2020-03-03T11:00:00Z","year":2020,"_id":"32114746","week":"202010|Mar 02 - Mar 08","doi":"10.3760/cma.j.cn112138-20200219-00097","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1661359647606439936,"score":76.60427},{"pmid":32149772,"title":"Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia.","text":["Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia.","Chin Med J (Engl)","Zeng, Yan-Ming","Xu, Xiao-Lei","He, Xiao-Qing","Tang, Sheng-Quan","Li, Yao","Huang, Yin-Qiu","Harypursat, Vijay","Chen, Yao-Kai","32149772"],"journal":"Chin Med J (Engl)","authors":["Zeng, Yan-Ming","Xu, Xiao-Lei","He, Xiao-Qing","Tang, Sheng-Quan","Li, Yao","Huang, Yin-Qiu","Harypursat, Vijay","Chen, Yao-Kai"],"date":"2020-03-10T11:00:00Z","year":2020,"_id":"32149772","week":"202011|Mar 09 - Mar 15","doi":"10.1097/CM9.0000000000000790","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1661359647798329344,"score":51.147793},{"pmid":32156329,"title":"Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system.","text":["Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system.","Facing the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), high-volume respiratory testing is demanded in laboratories worldwide. We evaluated the performance of a molecular assay for the detection of SARS-CoV-2 on a high-throughput platform, the cobas 6800, using the 'open channel' for integration of a laboratory-developed assay. We observed good analytical performance in clinical specimens. The fully automated workflow enables high-throughput testing with minimal hands-on time, while offering fast and reliable results.","Euro Surveill","Pfefferle, Susanne","Reucher, Svenja","Norz, Dominic","Lutgehetmann, Marc","32156329"],"abstract":["Facing the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), high-volume respiratory testing is demanded in laboratories worldwide. We evaluated the performance of a molecular assay for the detection of SARS-CoV-2 on a high-throughput platform, the cobas 6800, using the 'open channel' for integration of a laboratory-developed assay. We observed good analytical performance in clinical specimens. The fully automated workflow enables high-throughput testing with minimal hands-on time, while offering fast and reliable results."],"journal":"Euro Surveill","authors":["Pfefferle, Susanne","Reucher, Svenja","Norz, Dominic","Lutgehetmann, Marc"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32156329","week":"202011|Mar 09 - Mar 15","doi":"10.2807/1560-7917.ES.2020.25.9.2000152","keywords":["COVID-19","SARS-CoV-2","automation","high-throughput PCR","molecular diagnostic"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1661359647866486784,"score":42.367306}]}